LINGO-1 and its role in CNS repair - PubMed
Review
LINGO-1 and its role in CNS repair
Sha Mi et al. Int J Biochem Cell Biol. 2008.
Abstract
LINGO-1 is selectively expressed in the CNS on both oligodendrocyte precursor cells (OPCs) and neurons. Its expression is developmentally regulated in the normal CNS, as well as up-regulated in human or rat models of neuropathologies. LINGO-1 functions as a negative regulator of oligodendrocyte differentiation and myelination, neuronal survival and axonal regeneration. Across diverse animal CNS disease models, targeted LINGO-1 inhibition was found to promote neuron and oligodendrocyte survival, axon regeneration, oligodendrocyte differentiation, remyelination and improved functional recovery. The targeted inhibition of LINGO-1 therefore presents a novel therapeutic approach for the treatment of neurological diseases.
Similar articles
-
Knockdown of Lingo1b protein promotes myelination and oligodendrocyte differentiation in zebrafish.
Yin W, Hu B. Yin W, et al. Exp Neurol. 2014 Jan;251:72-83. doi: 10.1016/j.expneurol.2013.11.012. Epub 2013 Nov 18. Exp Neurol. 2014. PMID: 24262204
-
LINGO-1 negatively regulates myelination by oligodendrocytes.
Mi S, Miller RH, Lee X, Scott ML, Shulag-Morskaya S, Shao Z, Chang J, Thill G, Levesque M, Zhang M, Hession C, Sah D, Trapp B, He Z, Jung V, McCoy JM, Pepinsky RB. Mi S, et al. Nat Neurosci. 2005 Jun;8(6):745-51. doi: 10.1038/nn1460. Epub 2005 May 15. Nat Neurosci. 2005. PMID: 15895088
-
Mi S, Miller RH, Tang W, Lee X, Hu B, Wu W, Zhang Y, Shields CB, Zhang Y, Miklasz S, Shea D, Mason J, Franklin RJ, Ji B, Shao Z, Chédotal A, Bernard F, Roulois A, Xu J, Jung V, Pepinsky B. Mi S, et al. Ann Neurol. 2009 Mar;65(3):304-15. doi: 10.1002/ana.21581. Ann Neurol. 2009. PMID: 19334062
-
Blocking LINGO-1 as a therapy to promote CNS repair: from concept to the clinic.
Mi S, Pepinsky RB, Cadavid D. Mi S, et al. CNS Drugs. 2013 Jul;27(7):493-503. doi: 10.1007/s40263-013-0068-8. CNS Drugs. 2013. PMID: 23681979 Review.
-
Nogo-A and LINGO-1: Two Important Targets for Remyelination and Regeneration.
Kalafatakis I, Papagianni F, Theodorakis K, Karagogeos D. Kalafatakis I, et al. Int J Mol Sci. 2023 Feb 24;24(5):4479. doi: 10.3390/ijms24054479. Int J Mol Sci. 2023. PMID: 36901909 Free PMC article. Review.
Cited by
-
Scalabrino G. Scalabrino G. Cell Mol Neurobiol. 2022 May;42(4):891-916. doi: 10.1007/s10571-020-00989-x. Epub 2020 Nov 5. Cell Mol Neurobiol. 2022. PMID: 33151415 Free PMC article. Review.
-
Chen Y, Cao B, Yang J, Wei Q, Ou RW, Zhao B, Song W, Guo X, Shang H. Chen Y, et al. J Neurol. 2015 Nov;262(11):2478-83. doi: 10.1007/s00415-015-7870-9. Epub 2015 Aug 8. J Neurol. 2015. PMID: 26254004
-
Rice HC, Young-Pearse TL, Selkoe DJ. Rice HC, et al. Biochemistry. 2013 May 14;52(19):3264-77. doi: 10.1021/bi400165f. Epub 2013 May 2. Biochemistry. 2013. PMID: 23597280 Free PMC article.
-
Rashidbenam Z, Ozturk E, Pagnin M, Theotokis P, Grigoriadis N, Petratos S. Rashidbenam Z, et al. Front Cell Neurosci. 2023 Jun 8;17:1197492. doi: 10.3389/fncel.2023.1197492. eCollection 2023. Front Cell Neurosci. 2023. PMID: 37361998 Free PMC article. Review.
-
LINGO1 and LINGO2 variants are associated with essential tremor and Parkinson disease.
Vilariño-Güell C, Wider C, Ross OA, Jasinska-Myga B, Kachergus J, Cobb SA, Soto-Ortolaza AI, Behrouz B, Heckman MG, Diehl NN, Testa CM, Wszolek ZK, Uitti RJ, Jankovic J, Louis ED, Clark LN, Rajput A, Farrer MJ. Vilariño-Güell C, et al. Neurogenetics. 2010 Oct;11(4):401-8. doi: 10.1007/s10048-010-0241-x. Epub 2010 Apr 6. Neurogenetics. 2010. PMID: 20369371 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources